scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)

Q: What does CUSIP 810648105 represent in this 13F holders report?

CUSIP 810648105 is the security identifier for SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share in Q3 2020?

48 institutional investors reported SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share for Q3 2020. Use the holders table for investor-level position and value details.

CUSIP: 810648105

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 53,364,241
Total 13F shares: 17,093,245
Share change: -443,302
Total reported value: $127,345,487
Price per share: $7.45
Number of holders: 48
Value change: -$3,281,426
Number of buys: 21
Number of sells: 21

Quarterly Holders Quick Answers

What is CUSIP 810648105?
CUSIP 810648105 identifies SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2020
Previous quarter: Q2 2020

Recent filing periods for CUSIP 810648105:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	9%	4,797,148	$35,307,000	—	30 Jun 2020	13F
5AM Venture Management, LLC	13F	Company	7.2%	3,831,474	$28,200,000	—	30 Jun 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	6.6%	3,518,998	$25,900,000	—	30 Jun 2020	13F
Ikarian Capital, LLC	13F	Company	2.8%	1,468,647	$10,809,000	—	30 Jun 2020	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	1.4%	747,989	$5,505,000	—	30 Jun 2020	13F
VANGUARD GROUP INC	13F	Company	1.1%	587,599	$4,325,000	—	30 Jun 2020	13F
Alyeska Investment Group, L.P.	13F	Company	0.73%	388,603	$2,860,000	—	30 Jun 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.63%	333,686	$2,456,000	—	30 Jun 2020	13F
BlackRock Finance, Inc.	13F	Company	0.48%	258,360	$1,901,000	—	30 Jun 2020	13F
Eversept Partners, LP	13F	Company	0.46%	247,419	$1,821,004	—	30 Jun 2020	13F
Worth Venture Partners, LLC	13F	Company	0.33%	175,526	$1,292,000	—	30 Jun 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.29%	152,211	$1,120,000	—	30 Jun 2020	13F
SABBY MANAGEMENT, LLC	13F	Company	0.24%	125,752	$926,000	—	30 Jun 2020	13F
NORTHERN TRUST CORP	13F	Company	0.2%	108,678	$799,000	—	30 Jun 2020	13F
DAFNA Capital Management LLC	13F	Company	0.19%	100,000	$736,000	—	30 Jun 2020	13F
Hillsdale Investment Management Inc.	13F	Company	0.15%	82,300	$605,000	—	30 Jun 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.14%	75,252	$553,000	—	30 Jun 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.1%	54,277	$399,000	—	30 Jun 2020	13F
STATE STREET CORP	13F	Company	0.1%	52,681	$388,000	—	30 Jun 2020	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	39,200	$289,000	—	30 Jun 2020	13F
Alambic Investment Management, L.P.	13F	Company	0.07%	38,623	$284,000	—	30 Jun 2020	13F
MORGAN STANLEY	13F	Company	0.07%	38,309	$282,000	—	30 Jun 2020	13F
Squarepoint Ops LLC	13F	Company	0.07%	35,975	$265,000	—	30 Jun 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.06%	32,739	$241,000	—	30 Jun 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.05%	26,350	$194,000	—	30 Jun 2020	13F
Trexquant Investment LP	13F	Company	0.05%	25,973	$191,000	—	30 Jun 2020	13F
Walleye Capital LLC	13F	Company	0.04%	20,943	$154,000	—	30 Jun 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	19,012	$140,000	—	30 Jun 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.04%	18,959	$140,000	—	30 Jun 2020	13F
Matisse Capital	13F	Company	0.03%	17,685	$130,000	—	30 Jun 2020	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.03%	14,755	$108,000	—	30 Jun 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.03%	14,597	$108,000	—	30 Jun 2020	13F
Bank of New York Mellon Corp	13F	Company	0.03%	14,398	$106,000	—	30 Jun 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	13,000	$96,000	—	30 Jun 2020	13F
Tower Research Capital LLC (TRC)	13F	Company	0.02%	11,240	$83,000	—	30 Jun 2020	13F
Walleye Trading LLC	13F	Company	0.02%	10,424	$77,000	—	30 Jun 2020	13F
ExodusPoint Capital Management, LP	13F	Company	0.02%	10,013	$74,000	—	30 Jun 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	8,104	$60,000	—	30 Jun 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	3,939	$29,000	—	30 Jun 2020	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	3,287	$24,000	—	30 Jun 2020	13F
BARCLAYS PLC	13F	Company	0.01%	2,944	$22,000	—	30 Jun 2020	13F
DEUTSCHE BANK AG\	13F	Company	0%	2,474	$18,000	—	30 Jun 2020	13F
JPMORGAN CHASE & CO	13F	Company	0%	1,808	$13,000	—	30 Jun 2020	13F
UBS Group AG	13F	Company	0%	1,745	$13,000	—	30 Jun 2020	13F
Legal & General Group Plc	13F	Company	0%	879	$6,000	—	30 Jun 2020	13F
CITIGROUP INC	13F	Company	0%	704	$5,000	—	30 Jun 2020	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	475	$3,000	—	30 Jun 2020	13F
BANK OF MONTREAL /CAN/	13F	Company	0%	436	$3,000	—	30 Jun 2020	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	357	$3,000	—	30 Jun 2020	13F
FEDERATED HERMES, INC.	13F	Company	0%	255	$2,000	—	30 Jun 2020	13F

Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q3 2020

As of 30 Sep 2020, scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,093,245 shares. The largest 10 holders included ORBIMED ADVISORS LLC, 5AM Venture Management, LLC, RA CAPITAL MANAGEMENT, L.P., Ikarian Capital, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., and Worth Venture Partners, LLC. This page lists 48 institutional shareholders reporting positions in this security for the Q3 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders

Q3 2020 holders

Holder diff

-3

Investor	Q2 2020 Shares	Q3 2020 Shares	Share Diff	Share Chg %	Q2 2020 Value $	Q3 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.